WHO Expert Committee on Specifications for Pharmaceutical Preparations [meeting held in Geneva from 30 November to 4 December 1992] :
WHO Expert Committee on Specifications for Pharmaceutical Preparations [meeting held in Geneva from 30 November to 4 December 1992] : thirty-third report.
= Comité OMS d' experts des spécifications relatives aux préparations pharmaceutiques [réuni à Genève du 30 novembre au 4 décembre 1992] : trente-troisième rapport = Comité de Expertos de la OMS en Especificaciones para las Preparaciones Farmacéuticas [se reunió en Ginebra del 30 de noviembre al 4 de diciembre de 1992] : 33o informe
- Geneva : World Health Organization, 1993.
- 30 p.
- WHO technical report series ; 834 .
A progress report on a number of WHO-sponsored activities designed to support a comprehensive approach to the quality assurance of pharmaceutical products. Topics discussed include the continuing development of The International Pharmacopoeia, the establishment of International Chemical Reference Substances and International Infrared Reference Spectra, and the problem of substandard quality of several widely used drug substances. The report also issues recommendations concerning the small-scale preparation of eye drops, and a warning concerning the production of oral and injectable hormonal contraceptives in the absence of well established local programmes of drug regulation and quality assurance. Annexed to the report are guidelines for good manufacturing practices for biological products and up-dated lists of available Chemical Reference Substances and International Infrared Reference Spectra.
eng fre rus spa.
WHODOC
9241208341
Drug industry.
Pharmaceutical preparations--standards.
Quality control.
QV 771
A progress report on a number of WHO-sponsored activities designed to support a comprehensive approach to the quality assurance of pharmaceutical products. Topics discussed include the continuing development of The International Pharmacopoeia, the establishment of International Chemical Reference Substances and International Infrared Reference Spectra, and the problem of substandard quality of several widely used drug substances. The report also issues recommendations concerning the small-scale preparation of eye drops, and a warning concerning the production of oral and injectable hormonal contraceptives in the absence of well established local programmes of drug regulation and quality assurance. Annexed to the report are guidelines for good manufacturing practices for biological products and up-dated lists of available Chemical Reference Substances and International Infrared Reference Spectra.
eng fre rus spa.
WHODOC
9241208341
Drug industry.
Pharmaceutical preparations--standards.
Quality control.
QV 771